Insider Trading: Aastrom Biosciences Inc (ASTM.O)
ASTM.O on Consolidated Issue listed on NASDAQ Capital Market
0.57USD
17 May 2013
0.57USD
17 May 2013
Price Change (% chg)
$-0.02 (-3.39%)
$-0.02 (-3.39%)
Prev Close
$0.59
$0.59
Open
$0.59
$0.59
Day's High
$0.60
$0.60
Day's Low
$0.57
$0.57
Volume
177,156
177,156
Avg. Vol
472,991
472,991
52-wk High
$2.35
$2.35
52-wk Low
$0.52
$0.52
| DURBIN SCOTT C | Options Exercised: 0 | ||
| Trade Date: | Wednesday, 10 Aug 2011 | Price: | 2.24 |
| Title: | Chief Financial Officer | Shares Held: | 40,850 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 10,850 |
Institutional Holders
| % Shares Owned: | 10.68% |
| # of Holders: | 38 |
| Total Shares Held: | 4,875,617 |
| 3 Mo. Net Change: | 782,546 |
| # New Positions: | 4 |
| # Closed Positions: | 6 |
| # Increased Positions: | 14 |
| # Reduced Positions: | 11 |
| # Net Buyers: | 3 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Robert Zerbe |
61 | 2012 | Chairman of the Board |
Dominick Colangelo |
2013 | President, Chief Executive Officer, Director | |
Ronnda Bartel |
53 | 2010 | Chief Scientific Officer |
Brian Gibson |
33 | 2011 | Vice President - Finance |
Daniel Orlando |
2013 | Chief Business Officer | |
Nelson Sims |
64 | 2009 | Lead Independent Director |
Timothy Mayleben |
2012 | Director | |
Ronald Cresswell |
77 | 2010 | Independent Director |
Alan Rubino |
58 | 2005 | Independent Director |
Harold Urschel |
82 | 2009 | Independent Director |
Danielle Spangler |
IR Contact Officer |

